STOCK MARKET BSE NSE

Dr Reddy's initiates legal action against fraudulent entities offering Sputnik V vaccine

Dr Reddy's has fully put in place cold storage logistics as well as track-and-trace arrangements for the vaccine.

Published: 28th May 2021 07:59 PM  |   Last Updated: 28th May 2021 07:59 PM   |  A+A-

COVID Vaccine

For representational purposes (Photo | AP)

By PTI

NEW DELHI: Dr Reddy's Laboratories has not authorised any third party to supply the Sputnik V COVID-19 vaccine on its behalf in India and has initiated legal action against unscrupulous elements committing fraud in the name of the Russian vaccine, a statement said.

"Dr Reddy's Laboratories is the brand custodian of the Sputnik V vaccine in India and has the sole distribution rights of the first 250 million doses (first and second dose components included) of the vaccine in India," the domestic pharma major and Russian Direct Investment Fund (RDIF) said in a joint statement.

In the last few days, there have been several unsubstantiated reports and claims from various quarters in India on alleged tie-ups for the Sputnik V vaccine, it added.

"We wish to clarify that Dr Reddy's has not entered into any partnership or collaboration with any party to supply the Sputnik V vaccine to residential associations, nor has the company authorised any third party or intermediary to supply the vaccine on its behalf in India," it added.

Cautioning people, the statement asked them to beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine posing as the firm's representatives in India and asked them to alert the authorities immediately if approached.

"Dr Reddy's has initiated legal action against unscrupulous elements committing fraud in the name of the Sputnik V vaccine in India. The company takes no responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from such fraud," it added.

Dr Reddy's has fully put in place cold storage logistics as well as track-and-trace arrangements for the vaccine.

These arrangements are absolutely imperative to ensure the safety and quality of the vaccine, and for pharmacovigilance, the statement said.

"Ahead of the commercial launch of the vaccine in mid-June, Dr Reddy's continues to engage in direct talks with the Government and the private sector to explore partnerships," the statement added.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp